Key Points of Sun Pharma Acquire Stake in Vivaldis Health and Foods:
- Sun Pharmaceutical has signed an agreement to acquire a 60% stake in Vivaldis Health And Foods.
- Vivaldis Health And Foods Private Limited is a company engaged in the trading, manufacturing, and marketing of drugs, food supplements, and over-the-counter products for companion animals in the animal healthcare industry.
- The acquisition will be made from existing shareholders, with the remaining 40% shareholding to be acquired in the future as per certain terms and conditions.
- Vivaldis Health And Foods Private Limited is based in Pune, Maharashtra, India, and had a revenue of INR 29.92 crores in the financial year 2021-22.
- The cost of the acquisition for a 60% shareholding is INR 143.30 crores, subject to customary closing adjustments.
- The acquisition will strengthen Sun Pharma’s position in the animal healthcare industry and enable it to offer a wider range of products to its customers.
- Sun Pharma remains committed to enhancing its portfolio and expanding its reach in the healthcare industry, and this acquisition is a step towards achieving that goal.
Details of Sun Pharma Acquire Stake in Vivaldis Health and Foods:
Sun Pharmaceutical Industries Limited has recently announced that it has signed an agreement to acquire a 60% stake in Vivaldis Health And Foods Private Limited, a company engaged in the trading, manufacturing, and marketing of drugs, food supplements, and over-the-counter products for companion animals in the animal healthcare industry. The acquisition will be made from existing shareholders, with the remaining 40% shareholding to be acquired in the future as per certain terms and conditions.
Vivaldis Health And Foods Private Limited, incorporated under the Companies Act, 2013, is based in Pune, Maharashtra, India, and had a revenue of INR 29.92 crores in the financial year 2021-22. The cost of the acquisition for a 60% shareholding is INR 143.30 crores, subject to customary closing adjustments.
This acquisition will strengthen Sun Pharma’s position in the animal healthcare industry and enable it to offer a wider range of products to its customers. Sun Pharma remains committed to enhancing its portfolio and expanding its reach in the healthcare industry, and this acquisition is a step towards achieving that goal.
Sun Pharmaceutical Industries is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharma Ingredients (APIs). The company and its subsidiaries has various manufacturing facilities spread across the world with trading and other incidental and related activities extending to global market. It is the largest pharmaceutical company in India.
For More Latest News Click Here
